Analyst Ratings for Entasis Therapeutics (ETTX)

ETTX Rating Summary

ETTX Price Target Summary

* Over Last 12-Mos
  |   Expand Research on ETTX
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $6.60 (+179.7%) * Over Last 12-Mos
Rating Score: 10 / 10   Percentile Rank: 95%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
11/16/2020 Alliance Global Partners James Molloy New Coverage Buy
(N/A)
9.00
(N/A)
1.72
(2.36)
37.21% Details
9/9/2020 Cantor Fitzgerald Louise Chen New Coverage Overweight
(N/A)
5.00
(N/A)
2.76
(2.36)
-14.49% Details
Like ETTX Ratings? Also take a look at INVA, ZLAB

ETTX Ratings News